Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies (Details)

v3.24.3
Significant Accounting Policies (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Jan. 01, 2024
Jan. 01, 2023
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Mar. 17, 2015
Significant Accounting Policies                
Issuance of common shares - Founders Agreement     $ 318 $ 251 $ 714 $ 809    
Fortress Biotech, Inc                
Significant Accounting Policies                
Percentage of shares issued for offering and annual equity fee 2.50%             2.50%
Number of shares issued and sold 1,492,915 368,907     340,246 159,620    
Research and development                
Significant Accounting Policies                
Issuance of common shares - Founders Agreement             $ 3,400